AEOLUS PHARMACEUTICALS, INC.
AEOLUS PHARMACEUTICALS, INC. (AOLS): 6 pipeline candidates · ~3 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
2.7 months
D/E 2.84 · 0% dilution
Lead: Preclinical
6 candidates
N/A
N/A
A transparent, data-derived signal for AEOLUS PHARMACEUTICALS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$15K
Cash
$403K
Quarterly Burn
$578K
Runway
2.7 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| aeol 10113 | Preclinical |
| aeol 10150 | Preclinical |
| aeol 10171 | Preclinical |
| aeol 11114b | Preclinical |
| aeol 11207 | Preclinical |
| aeol 20415 | Preclinical |
Frequently asked questions
How many drug candidates are in AEOLUS PHARMACEUTICALS, INC.'s pipeline?
AEOLUS PHARMACEUTICALS, INC. (AOLS) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is AEOLUS PHARMACEUTICALS, INC.'s lead drug candidate?
AEOLUS PHARMACEUTICALS, INC.'s most advanced tracked candidate is aeol 10113 (Preclinical) for Radiation mitigator.
What is AEOLUS PHARMACEUTICALS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, AEOLUS PHARMACEUTICALS, INC. has approximately 2.7 months of cash runway.
What is AEOLUS PHARMACEUTICALS, INC.'s market capitalization?
AEOLUS PHARMACEUTICALS, INC.'s market capitalization is approximately $15K.
Get the full picture on AEOLUS PHARMACEUTICALS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.